John A. Ward

Array ( [id] => 5922448 [patent_doc_number] => 20060240500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Diagnosis of kidney damage and protection against same' [patent_app_type] => utility [patent_app_number] => 10/524237 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37042 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240500.pdf [firstpage_image] =>[orig_patent_app_number] => 10524237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177412 [patent_doc_number] => 20070178472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Methods of identifying adipocyte specific genes, the genes identified, and their uses' [patent_app_type] => utility [patent_app_number] => 10/630423 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25123 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178472.pdf [firstpage_image] =>[orig_patent_app_number] => 10630423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7374717 [patent_doc_number] => 20040093622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Generation of xenogeneic antibodies' [patent_app_type] => new [patent_app_number] => 10/627250 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23815 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20040093622.pdf [firstpage_image] =>[orig_patent_app_number] => 10627250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364631 [patent_doc_number] => 20040091995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses' [patent_app_type] => new [patent_app_number] => 10/297168 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23336 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091995.pdf [firstpage_image] =>[orig_patent_app_number] => 10297168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045136 [patent_doc_number] => 20050249731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Methods of implating mesenchymal stem cells for tissue repair and formation' [patent_app_type] => utility [patent_app_number] => 10/520271 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8389 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249731.pdf [firstpage_image] =>[orig_patent_app_number] => 10520271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303197 [patent_doc_number] => 20040115174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Angio-immunotherapy' [patent_app_type] => new [patent_app_number] => 10/613262 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10079 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115174.pdf [firstpage_image] =>[orig_patent_app_number] => 10613262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369511 [patent_doc_number] => 20040016007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof' [patent_app_type] => new [patent_app_number] => 10/276572 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5601 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20040016007.pdf [firstpage_image] =>[orig_patent_app_number] => 10276572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7309997 [patent_doc_number] => 20040117863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Transgenically produced fusion proteins' [patent_app_type] => new [patent_app_number] => 10/608710 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21465 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20040117863.pdf [firstpage_image] =>[orig_patent_app_number] => 10608710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 852895 [patent_doc_number] => 07378277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Methods and compositions for transforming dendritic cells and activating T cells' [patent_app_type] => utility [patent_app_number] => 10/607327 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 18424 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378277.pdf [firstpage_image] =>[orig_patent_app_number] => 10607327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224340 [patent_doc_number] => 20040072728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Use of streptavidin to inhibit transplant rejection' [patent_app_type] => new [patent_app_number] => 10/608841 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3025 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072728.pdf [firstpage_image] =>[orig_patent_app_number] => 10608841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6914118 [patent_doc_number] => 20050177876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Fcyriia transgenic animal model for autoimmune disease' [patent_app_type] => utility [patent_app_number] => 10/517251 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11742 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20050177876.pdf [firstpage_image] =>[orig_patent_app_number] => 10517251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7458754 [patent_doc_number] => 20040010810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Generation of xenogeneic antibodies' [patent_app_type] => new [patent_app_number] => 10/455013 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25353 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010810.pdf [firstpage_image] =>[orig_patent_app_number] => 10455013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635210 [patent_doc_number] => 20030211598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Compositions and methods for therapeutic use' [patent_app_type] => new [patent_app_number] => 10/454662 [patent_app_country] => US [patent_app_date] => 2003-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6510 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211598.pdf [firstpage_image] =>[orig_patent_app_number] => 10454662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456200 [patent_doc_number] => 07893033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Targeting proteins to deliver therapeutic or diagnostic reagents' [patent_app_type] => utility [patent_app_number] => 10/430503 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27087 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893033.pdf [firstpage_image] =>[orig_patent_app_number] => 10430503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220842 [patent_doc_number] => 20040072288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods for altering cell fate to generate T-cells specific for an antigen of interest' [patent_app_type] => new [patent_app_number] => 10/426595 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 34912 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072288.pdf [firstpage_image] =>[orig_patent_app_number] => 10426595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176025 [patent_doc_number] => 20040078834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression' [patent_app_type] => new [patent_app_number] => 10/427629 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7915 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20040078834.pdf [firstpage_image] =>[orig_patent_app_number] => 10427629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679764 [patent_doc_number] => 20030229905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Generation of xenogeneic antibodies' [patent_app_type] => new [patent_app_number] => 10/421011 [patent_app_country] => US [patent_app_date] => 2003-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 23838 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229905.pdf [firstpage_image] =>[orig_patent_app_number] => 10421011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111721 [patent_doc_number] => 20050209177 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-09-22 [patent_title] => 'Combined therapeutical treatment of hyperproliferative diseases' [patent_app_type] => utility [patent_app_number] => 10/412684 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6926 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0209/20050209177.pdf [firstpage_image] =>[orig_patent_app_number] => 10412684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111721 [patent_doc_number] => 20050209177 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-09-22 [patent_title] => 'Combined therapeutical treatment of hyperproliferative diseases' [patent_app_type] => utility [patent_app_number] => 10/412684 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6926 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0209/20050209177.pdf [firstpage_image] =>[orig_patent_app_number] => 10412684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443035 [patent_doc_number] => 07256181 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta' [patent_app_type] => utility [patent_app_number] => 10/395712 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 18312 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256181.pdf [firstpage_image] =>[orig_patent_app_number] => 10395712 [rel_patent_id] =>[rel_patent_doc_number] =>)